Healthcare

Is It Time to Pay Attention to PME Shares?

Pro Medicus Limited,(ASX: PME),has garnered attention due to its notable performance in 2024, with the company’s share price rising by a substantial m...

Regis Healthcare Reaches Nine-Year High on Strategic Acquisition

Regis Healthcare (ASX: REG) has surged to an impressive intraday peak of $6.12, marking its highest price since 2015. This notable increase is largely...

Regis Healthcare (ASX: REG) Share Price Rises on Acquisition and Age...

Regis Healthcare Ltd,(ASX: REG),has seen its share price rise by 4% following the announcement of a significant acquisition and a response to recent a...

REG Acquires Two Melbourne Aged Care Facilities for $35.5 Million

Regis Healthcare Limited (ASX: REG), a leading provider of aged care services in Australia, has announced the acquisition of two aged care facilities...

CSL Ltd (ASX:CSL) Announces Leadership Changes: John Levy Steps in a...

CSL Ltd (ASX:CSL), a global leader in biotechnology, has announced significant leadership changes within its financial department. John Levy will assu...

Health Check: Cann Group Experiences Earnings Turnaround Amidst Chal...

Cann Group (ASX: CAN), a pioneer in the medical cannabis sector, is signaling a turnaround after facing significant challenges. The company, which pos...

ResMed Shares Take a Hit on Thursday. Here’s Why.

Shares of ResMed (ASX:RMD) are experiencing a significant decline on Thursday, with the stock down 3.5% to AU$34.98 after opening at AU$35.30, compare...

Key Reasons to Keep an Eye on CSL Ltd and Pro Medicus Shares

Since the beginning of 2024, shares of CSL Ltd have risen by 2.5%, while Pro Medicus Limited is trading just 1.3% away from its 52-week high. Let’s ta...

Surge in Yoghurt Sales Boosts Bega's Market Value

Bega Cheese Limited (ASX: BGA), a major player in the Australian dairy industry, has experienced a significant increase in market capitalisation, addi...

Ramsay Health Care Limited (ASX:RHC) Price-to-Earnings Ratio: A Clos...

Ramsay Health Care Limited (ASX:RHC) currently holds a price-to-earnings (P/E) ratio of 36.3x, significantly higher than the market average in Austral...

Does LuPSMA Represent a Breakthrough in Treating Metastatic Prostate...

A significant study conducted by the,Peter MacCallum Cancer Centre,(Peter Mac) has demonstrated the potential of targeted radioactive infusion for enh...

FDA Provides Guidance for Paradigm Biopharma's Phase 3 Osteoarthriti...

Paradigm Biopharmaceuticals (ASX:PAR) has received significant feedback from the U.S. Food and Drug Administration (FDA) regarding its Phase 3 clinica...

Botanix Pharmaceuticals Ltd (ASX: BOT) to Launch Sofdra for Excessiv...

Botanix Pharmaceuticals Ltd (ASX: BOT) has announced an upcoming launch of its approved product, Sofdra, for treating primary axillary hyperhidrosis (...

Pacific Smiles Group (ASX:PSQ) Receives New Takeover Offer from Beam...

Pacific Smiles Group Ltd (ASX:PSQ), a prominent dental centre operator in Australia, has recently received an off-market takeover proposal from Beam D...

Dimerix (ASX: DXB) Partners with UK’s RaDaR to Advance FSGS Treatmen...

Dimerix,(ASX: DXB),has recently announced a significant collaboration with the UK’s National Registry of Rare Kidney Diseases (RaDaR) to enhance its A...

ResMed CDI (ASX: RMD) Sees Strong 2024 Performance: A Closer Look

The share price of ResMed CDI,(ASX: RMD),has surged by 45.3% since the beginning of 2024. This substantial increase has drawn attention to the company...

Regis Healthcare Ltd (ASX: REG) Sees Impressive Gains: What Does the...

Regis Healthcare Ltd,(ASX: REG),has seen a remarkable 31% increase in its share price over the past month, contributing to an impressive 112% annual g...

BlinkLab (ASX: BB1) Partners with INTER-PSY to Advance Autism Diagno...

BlinkLab has embarked on a significant partnership with INTER-PSY to advance the capabilities of its autism diagnostic platform. This collaboration ai...

CSL Ltd (ASX: CSL) Shares Up 4% in 2024: Should They Be on Your Rada...

CSL Ltd has seen its share price climb 4.0% since the beginning of 2024. As an,ASX healthcare stock,, this rise reflects the company’s ongoing commitm...

GTI extends uranium mineralisation at Lo Hema through development dr...

Clarity Pharmaceuticals Ltd (ASX:CU6) has announced progress in its ongoing SECuRE trial, with positive safety results from the latest stage. The tria...